Monitor the CEO presentations for any updates on the DLB psychosis registration program, but no immediate trading catalyst is expected from this announcement alone.
Price Chart
Executive Summary
Cognition Therapeutics announced its CEO will present at the Jefferies Global Healthcare Conference (June 4) and H.C. Wainwright Neuro Perspectives Summit (on-demand from June 15) to provide updates on the planned registration program for zervimesine in DLB psychosis. No financial data was disclosed; the press release is a routine corporate update.
Key Facts
- CEO Lisa Ricciardi to present at 2026 Jefferies Global Healthcare Conference on June 4 at 1:25 p.m. ET.
- CEO to present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit on-demand beginning June 15 at 8:00 a.m. ET.
- Company plans to advance zervimesine (CT1812) into a late-stage clinical trial for DLB psychosis following positive Phase 2 SHIMMER study results.
- No new financial or clinical data released in this announcement.
Financial Impact
No financial impact from this press release.
Risk Factors
- Clinical trial risks for zervimesine in DLB psychosis.
- Regulatory uncertainties regarding the registration program.
- Dependence on future financing for clinical development.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304237 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.7010 $0.7188 | ▲ +2.54% | ▲ +3.06% | $0.7196 (+2.65%) |
Jun 4, 2026 20w ago | 8-K | $1.36 $1.29 | ▼ −5.15% | ▼ −2.55% | $0.7196 (−47.09%) |
Jun 1, 2026 21w ago | Press Release | $1.25 $1.35 | ▲ +8.00% | ▲ +7.86% | $0.7196 (−42.43%) |
May 21, 2026 22w ago | Press Release | $1.25 $1.26 | ▲ +0.80% | ▲ +0.35% | $0.7196 (−42.43%) |
May 14, 2026 23w ago | Press Release | $1.20 $1.14 | ▼ −5.00% | ▼ −3.77% | $0.7196 (−40.03%) |
May 7, 2026 24w ago | 8-K | $1.21 $1.18 | ▼ −2.48% | ▼ −2.71% | $0.7196 (−40.53%) |
Apr 16, 2026 27w ago | Insider Cluster | $1.11 $1.19 | ▲ +7.21% | ▲ +5.99% | $0.7196 (−35.17%) |
Mar 26, 2026 30w ago | Press Release | $1.08 $0.7300 | ▼ −32.41% | ▼ −30.73% | $0.7196 (−33.37%) |
Mar 23, 2026 31w ago | Press Release | $1.13 $1.10 | ▼ −2.65% | ▼ −2.30% | $0.7196 (−36.32%) |
Mar 17, 2026 31w ago | Press Release | $1.15 $1.10 | ▼ −4.35% | ▼ −2.95% | $0.7196 (−37.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers